Alkermes
ALKS
#3169
Rank
A$6.99 B
Marketcap
A$42.39
Share price
-0.98%
Change (1 day)
-12.84%
Change (1 year)

Alkermes (ALKS) - Total debt

Total debt on the balance sheet as of September 2025 : A$0.10 Billion

According to Alkermes's latest financial reports the company's total debt is A$0.10 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Alkermes - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31A$0.12 B-77.77%
2023-12-31A$0.54 B-2.03%
2022-12-31A$0.55 B-2.88%
2021-12-31A$0.57 B7.63%
2020-12-31A$0.53 B28.36%
2019-12-31A$0.41 B4.81%
2018-12-31A$0.39 B9.98%
2017-12-31A$0.36 B-8.4%
2016-12-31A$0.39 B-18.08%
2015-12-31A$0.48 B10.51%
2014-12-31A$0.43 B
2013-03-31A$0.35 B-17.23%
2012-03-31A$0.42 B
2010-03-31A$55.44 M-48.93%
2009-03-31A$0.10 B-37.65%
2008-03-31A$0.17 B-11.23%
2007-03-31A$0.19 B-50.8%
2006-03-31A$0.39 B10.98%
2005-03-31A$0.35 B112.6%
2004-03-31A$0.16 B-41.55%
2003-03-31A$0.28 B-30.47%
2002-03-31A$0.41 B-9.81%
2001-03-31A$0.46 B21.79%
2000-03-31A$0.37 B513.29%
1999-03-31A$61.71 M132.72%
1998-03-31A$26.52 M43.77%
1997-03-31A$18.44 M12.96%
1996-03-31A$16.32 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Acorda Therapeutics
ACOR
A$0.29 B 173.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$76.83 B 71,188.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$68.93 B 63,861.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$91.59 B 84,885.61%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$49.12 B 45,476.69%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$25.69 B 23,745.64%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Zogenix
ZGNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$38.43 B 35,559.24%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
A$48.20 B 44,624.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland